CoChat

Renal denervation in patients with chronic kidney disease: current evidence and future perspectives

Open access
Schmieder, Roland E · 2023 · Nephrology Dialysis Transplantation

The DOI matches its Crossref record; 64 of the 65 references it cites were found in a registry or an index.

Abstract

Supported by several high-quality randomized controlled trials and registry analyses, catheter-based renal denervation is becoming an important adjunctive treatment modality for the safe and efficacious treatment of hypertension besides lifestyle modifications and antihypertensive medication. Renal denervation is of particular interest to nephrologists as the intervention may provide additional benefits to hypertensive people with chronic kidney disease (CKD), a condition typically characterized by sympathetic hyperactivity. A growing body of clinical evidence supports the safety and efficacy of renal denervation in this difficult-to-control population. In addition, preclinical and clinical research works indicate potential nephroprotective effects in CKD patients. The current review examines recent research on renal denervation with a focus on renal disease and assesses the latest findings and their implications from a nephrologist's perspective.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ndt/gfac189

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1: Effect of bilateral nephrectomy on SNS activity in renal transplant patients. From Hausberg et al [12]. MSNA, muscle sympathetic activity; CVR, calf vascular resistance; n.s., not significant.
FIGURE 1: Effect of bilateral nephrectomy on SNS activity in renal transplant patients. From Hausberg et al [12]. MSNA, muscle sympathetic activity; CVR, calf vascular resistance; n.s., not significant.CC BY-NC · PubMed Central
FIGURE 2: Changes in 24-h ambulatory BP (top) and office BP (bottom), respectively, after renal denervation (A and C) and sham (B and D) treatment in sham-controlled RCTs with second-generation technologies.
FIGURE 2: Changes in 24-h ambulatory BP (top) and office BP (bottom), respectively, after renal denervation (A and C) and sham (B and D) treatment in sham-controlled RCTs with second-generation technologies.CC BY-NC · PubMed Central
FIGURE 3: Changes from baseline with renal denervation or sham up to 36 months in the randomized, sham-controlled SPYRAL-ON MED study. Medication changes were allowed after end of primary follow-up at 6 months and patients were unblinded to randomization status at 12 months. Adapted from Mahfoud et al [27].
FIGURE 3: Changes from baseline with renal denervation or sham up to 36 months in the randomized, sham-controlled SPYRAL-ON MED study. Medication changes were allowed after end of primary follow-up at 6 months and patients were unblinded to randomization status at 12 months. Adapted from Mahfoud et al [27].CC BY-NC · PubMed Central
FIGURE 4: Muscle sympathetic nerve activity (MSNA) expressed as burst frequency (bs/min; blue bars; left-hand scale) and burst incidence (bs/100 heartbeats; green bars; right-hand scale) in patients and healthy individuals grouped according to progressively more severe degrees of renal dysfunction. Adapted from Grassi et al [43].
FIGURE 4: Muscle sympathetic nerve activity (MSNA) expressed as burst frequency (bs/min; blue bars; left-hand scale) and burst incidence (bs/100 heartbeats; green bars; right-hand scale) in patients and healthy individuals grouped according to progressively more severe degrees of renal dysfunction. Adapted from Grassi et al [43].CC BY-NC · PubMed Central
FIGURE 5: Mean basal total urinary NOx (nitrate + nitrite) excretion (V) in normotensive (control) and hypertensive sheep with CKD 2 and 30 months after renal denervation or sham procedures, respectively. Lines indicate standard error. *P < .05 comparing sham groups at follow-up. ##P < .05, ####P < .0001 comparing sham and treated groups at follow-up. From Singh et al [58].
FIGURE 5: Mean basal total urinary NOx (nitrate + nitrite) excretion (V) in normotensive (control) and hypertensive sheep with CKD 2 and 30 months after renal denervation or sham procedures, respectively. Lines indicate standard error. *P < .05 comparing sham groups at follow-up. ##P < .05, ####P < .0001 comparing sham and treated groups at follow-up. From Singh et al [58].CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 45

Metadata

Authors
Schmieder, R. E.
Affiliations
Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
Corresponding author
Schmieder, Roland E
Venue
Nephrology Dialysis Transplantation
Published
2022-05-25
Volume
38
Issue
5
Pages
1089-1096
ISSN
  • 0931-0509 (ISSN-L)
  • 1460-2385
OpenAlex
W4281568867
Cited by
39
References
65
Citations by year
2026: 9 · 2025: 13 · 2024: 6 · 2023: 10 · 2022: 1
FWCI
1.53
Type
journal article
Language
en
Open access
Locations
  • Nephrology Dialysis Transplantation (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Medtronic
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Nephrology › Renal and Vascular Pathologies
Keywords
renal denervation, chronic kidney disease, hypertension, catheter ablation, sympathetic hyperactivity, renal protection, adjunctive therapy, antihypertensive therapy
MeSH terms
Antihypertensive Agents, Blood Pressure, Denervation, Humans, Hypertension, Kidney, Sympathectomy, Treatment Outcome, Renal Insufficiency, Chronic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.